Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects
Clinical trial NCT01766921 · COMPLETED
Trial details
- NCT number
- NCT01766921
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2013-07-01
- Enrollment
- 1393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.